To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of ...
Read MoreThe investment objective of the scheme is to provide returns before expenses that correspond to the total return of the underlying index subject to tracking errors. However, there can be no assurance ...
Read MoreThe investment objective of the scheme is to seek to generate returns by investing in arbitrage opportunities in the cash and derivatives segments of the equity markets and by investing balance in deb...
Read MoreThe investment objective of the scheme is to seek to generate long term capital appreciation by investing in multi asset classes including equity and equity related securities, debt and money market i...
Read MoreThe investment objective of the fund is to generate long term capital appreciation/income by investing in equity and debt instruments. However, there is no assurance or guarantee that the investment o...
Read MoreThe primary objective of the scheme is to provide long-term capital appreciation/income by investing across market capitalisations and managing a diversified portfolio of Large Cap, Mid Cap & Small Ca...
Read MoreThe investment objective of the scheme is to generate long term capital appreciation by investing in Equity & Equity related Securities, Debt & Money Market Instruments, Commodity ETFs and Exchange Tr...
Read MoreTo provide long-term capital appreciation by investing predominantly in equity and equity related securities of Technology & technology related companies. There is no assurance that the investment obj...
Read MoreThe primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related instruments of technology-centric companies. However, there can be no...
Read MoreThe investment objective of the scheme is to generate returns that are commensurate with the performance of the S&P BSE SENSEX Index, subject to tracking errors. There is no assurance that the investm...
Read More